EUVIMEDEUVIMED entdecken
Open Access

Targeting the exosomal CaMK2A-ZDHHC3-GPX4 pathway reprograms tumor-associated macrophages and enhances anti-PD-1/PD-L1 immunotherapy in gastric cancer

Zetian Chen, Hongxin Huang, Yikai Shen, Masami Yamamoto, Tetsuya Tsukamoto, Sachiyo Nomura, Tianlu Jiang, Zekuan Xu, Zheng Li

International Journal of Biological Sciences · 2026

DOI: 10.7150/ijbs.128976 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2026. Verfasst von Zetian Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Gastric Cancer Center, Department of General Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Exosomes, Tumor-Associated Macrophages, Calcium-Calmodulin-Dependent Protein Kinase Type 2. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gastric cancer (GC) remains a major global health challenge, characterized by poor outcomes driven by an immunosuppressive tumor microenvironment (TME). Tumor-associated macrophages (TAMs), particularly the M2 subtype, are central mediators of immune evasion and therapeutic resistance. While tumor-derived exosomes are key regulators of intercellular communication, the mechanisms by which they modulate TAM fate remain unclear.

Methods

Proteomic profiling, molecular assays, and in vivo models were used to identify GC-derived exosomal cargos regulating macrophage polarization. The CaMK2A-ZDHHC3-GPX4 axis was dissected using phosphorylation, palmitoylation, and genetic perturbation analyses. The therapeutic implications were evaluated through macrophage-specific GPX4 ablation and anti-PD-1/PD-L1 blockade in murine GC models.

Results

We identified exosomal CaMK2A as a critical determinant of TAM polarization. Internalized CaMK2A phosphorylates ZDHHC3 at Thr176, enhancing GPX4 S-palmitoylation at Cys10, preventing its lysosomal degradation, and stabilizing GPX4 protein. This cascade suppresses macrophage ferroptosis and promotes M2 polarization, fostering tumor proliferation and metastasis. Conversely, GPX4 deletion in macrophages restrains tumor growth and synergizes with PD-1/PD-L1 blockade to enhance antitumor immunity. Clinically, GPX4 is upregulated in GC, enriched in TAMs, and predicts poor prognosis.

Conclusions

Our study reveals a previously unrecognized CaMK2A-ZDHHC3-GPX4 signaling axis that couples ferroptosis resistance to immunosuppressive TAM polarization. Targeting GPX4 or disrupting exosomal CaMK2A signaling may reprogram the TME and potentiate immune checkpoint therapy in GC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsExosomesTumor-Associated MacrophagesCalcium-Calmodulin-Dependent Protein Kinase Type 2AnimalsMiceHumansTumor MicroenvironmentB7-H1 AntigenImmunotherapyProgrammed Cell Death 1 ReceptorCell Line, TumorSignal Transduction

Stichwörter der Autor:innen

GPX4exosomesimmunotherapypalmitoylationtumor-associated macrophages

Substanzen

Calcium-Calmodulin-Dependent Protein Kinase Type 2B7-H1 AntigenProgrammed Cell Death 1 Receptor

Autor:innen und Institutionen

  • Gastric Cancer Center, Department of General Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China.
  • Jiangsu Provincial Key Laboratory of Chronic Digestive Diseases, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China.
  • Department of Pathology, Nippon Veterinary and Life Science University, Tokyo, Japan.
  • Department of Pathology, Graduate School of Medicine, Fujita Health University, Toyoake, Japan.
  • Department of Gastrointestinal Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Department of General Surgery, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, Jiangsu, China.

Zitieren

APA

Chen, Z., Huang, H., Shen, Y., Yamamoto, M., Tsukamoto, T., Nomura, S., Jiang, T., Xu, Z., & Li, Z. (2026). Targeting the exosomal CaMK2A-ZDHHC3-GPX4 pathway reprograms tumor-associated macrophages and enhances anti-PD-1/PD-L1 immunotherapy in gastric cancer. International Journal of Biological Sciences. https://doi.org/10.7150/ijbs.128976

Vancouver

Chen Z, Huang H, Shen Y, Yamamoto M, Tsukamoto T, Nomura S, et al. Targeting the exosomal CaMK2A-ZDHHC3-GPX4 pathway reprograms tumor-associated macrophages and enhances anti-PD-1/PD-L1 immunotherapy in gastric cancer. International Journal of Biological Sciences. 2026. doi:10.7150/ijbs.128976

BibTeX
@article{Chen2026,
  author = {Chen, Zetian and Huang, Hongxin and Shen, Yikai and Yamamoto, Masami and Tsukamoto, Tetsuya and Nomura, Sachiyo and Jiang, Tianlu and Xu, Zekuan and Li, Zheng},
  title = {Targeting the exosomal CaMK2A-ZDHHC3-GPX4 pathway reprograms tumor-associated macrophages and enhances anti-PD-1/PD-L1 immunotherapy in gastric cancer},
  journal = {International Journal of Biological Sciences},
  year = {2026},
  doi = {10.7150/ijbs.128976}
}
Kostenlos starten →